Reuters logo
3 months ago
BRIEF-India's Cadila Healthcare says Zydus Cadila gets USFDA nod to market levofloxacin
June 2, 2017 / 4:00 AM / 3 months ago

BRIEF-India's Cadila Healthcare says Zydus Cadila gets USFDA nod to market levofloxacin

June 2 (Reuters) - Cadila Healthcare Ltd

* Says Zydus Cadila received final approval from USFDA to market levofloxacin injection

* Levofloxacin used in treating bacterial infections; levofloxacin will be produced at manufacturing facility at Moraiya Source text - (bit.ly/2skmZJH) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below